Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Q Therapeutics, Inc.
CIK: 1366541
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-10-24
Last Filing Date: 2015-11-13
SEC Filings
Start End Frame Filed ACCN Value View
2011-06-01 2011-08-31 CY2011Q3 2011-12-02 0001504412-11-000163 $ 1,377,174 View
2002-03-29 2008-12-31 CY2011 2012-03-23 0001387131-12-000814 $ 9,800 View
2012-01-01 2012-03-31 CY2011Q1 2012-05-16 0001493152-12-000484 $ 24,636,955 View
2012-04-01 2012-06-30 CY2011Q2 2012-09-10 0001493152-12-001231 $ 24,675,874 View
2012-07-01 2012-09-30 CY2011Q3 2012-11-13 0001493152-12-001581 $ 24,685,193 View
2012-01-01 2012-12-31 CY2011 2013-03-28 0001193125-13-132420 $ 24,683,787 View
2015-01-01 2015-03-31 CY2015Q1 2015-05-11 0001193125-15-182168 $ 30,685,985 View
2015-04-01 2015-06-30 CY2015Q2 2015-08-14 0001193125-15-291454 $ 30,826,549 View
2015-07-01 2015-09-30 CY2015Q3 2015-11-13 0001193125-15-376922 $ 30,826,549 View
2010-06-01 2011-05-31 CY2010 2011-10-24 0001504412-11-000118 $ 100,000 View
2013-01-01 2013-03-31 CY2012Q1 2013-05-03 0001193125-13-198882 $ 24,778,221 View
2013-04-01 2013-06-30 CY2012Q2 2013-08-13 0001193125-13-332838 $ 24,803,225 View
2013-07-01 2013-09-30 CY2012Q3 2013-11-14 0001193125-13-442024 $ 24,839,007 View
2013-01-01 2013-12-31 CY2012 2014-04-15 0001193125-14-144283 $ 24,839,755 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-15 0001193125-14-201193 $ 25,017,018 View
2014-04-01 2014-06-30 CY2013Q2 2014-07-31 0001193125-14-289872 $ 29,182,858 View
2014-07-01 2014-09-30 CY2013Q3 2014-11-07 0001193125-14-403654 $ 30,352,605 View
2014-01-01 2014-12-31 CY2014 2015-03-31 0001193125-15-114403 $ 28,944,366 View
SEC Facts By Type
Type Name Description View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Cash, Period Increase (Decrease) Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals. View
us-gaap Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. View
us-gaap Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss Loss recognized as a result of the initial and subsequent write-down of a long-lived asset's carrying amount to fair value. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap License and Services Revenue (Deprecated 2018-01-31) Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. View
us-gaap Notes Payable, Related Parties, Current (Deprecated 2009-01-31) The amount for notes payable (written promise to pay), due to related parties. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) Value of shares issued as consideration for cash for development stage entities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Property, Plant and Equipment Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
invest Investment Warrants, Exercise Price Exercise price of the warrants. View
us-gaap Accounts and Other Receivables, Net, Current Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer. View
us-gaap Accounts Payable and Accrued Liabilities, Noncurrent Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Construction Contractor, Receivable, Excluding Contract Retainage Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract. View
us-gaap Accretion Expense, Including Asset Retirement Obligations Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies. View
us-gaap Accrued Bonuses, Current Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. View
us-gaap Accrued Professional Fees, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Salaries, Current Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Salaries Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. View
us-gaap Accrued Vacation, Current Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Vacation Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Accounts Receivable, Allowance for Credit Loss, Current Amount of allowance for credit loss on accounts receivable, classified as current. View
us-gaap Allowance for Doubtful Other Receivables, Current Amount of valuation allowance for receivables classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Allowance for Loan and Lease Losses, Recoveries of Bad Debts (Deprecated 2013-01-31) Reflects a reduction in bad debt expense attributable to collections of loans and lease receivables which had previously been fully or partially charged off as bad debts. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Asset Impairment Charges Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. View
us-gaap Bridge Loan Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing. View
us-gaap Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Conversion of Stock, Amount Issued "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Conversion of Stock, Shares Issued "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Converted Instrument, Shares Issued "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or payments in the period." View
us-gaap Debt Conversion, Original Debt, Amount "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) Interest expense related to convertible debt instruments which has been recognized for the period, including the contractual interest coupon and amortization of the debt discount, if any. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Debt Instrument, Interest Rate, Effective Percentage Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. View
us-gaap Debt Instrument, Interest Rate, Stated Percentage Contractual interest rate for funds borrowed, under the debt agreement. View
us-gaap Debt Instrument, Redemption Price, Percentage Percentage price of original principal amount of debt at which debt can be redeemed by the issuer. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Debt Issuance Cost (Deprecated 2016-01-31) Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). View
us-gaap Debt Issuance Costs, Current, Net Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Deferred Tax Assets, Valuation Allowance, Current Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as current. View
us-gaap Deferred Tax Assets, Valuation Allowance, Noncurrent Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent. View
us-gaap Defined Contribution Plan, Employer Discretionary Contribution Amount Amount of discretionary contributions made by an employer to a defined contribution plan. View
us-gaap Deposits Assets, Noncurrent Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. View
us-gaap Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. View
us-gaap Depreciation, Nonproduction The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives. View
us-gaap Derivative, Gain (Loss) on Derivative, Net Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. View
us-gaap Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability. View
us-gaap Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Due from Related Parties, Noncurrent Aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due after one year (or one business cycle). View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Amount of cost not yet recognized for nonvested award under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Grants Receivable Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. View
us-gaap Grants Receivable, Current Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Derivative Liabilities The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). View
us-gaap Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Increase (Decrease) in Other Receivables Amount of increase (decrease) in receivables classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Expense, Debt Amount of the cost of borrowed funds accounted for as interest expense for debt. View
us-gaap Interest Income, Other Amount of interest income earned from interest bearing assets classified as other. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Payable Amount of interest payable on debt, including, but not limited to, trade payables. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Leveraged Buyout, Ownership Interest of New Investors (Deprecated 2013-01-31) Percentage of ownership interest held by new shareholders. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) Aggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity. View
us-gaap License Costs (Deprecated 2018-01-31) Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Long-term Purchase Commitment, Amount The minimum amount the entity agreed to spend under the long-term purchase commitment. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued "The number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Financing Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable. View
us-gaap Notes Assumed The fair value of notes assumed in noncash investing or financing activities. View
us-gaap Notes Issued The fair value of notes issued in noncash investing and financing activities. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Notes Reduction The value of notes retired (or transferred to another entity) in noncash investing or financing transactions. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Leases, Future Minimum Payments Due, Next Twelve Months Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Future Minimum Payments, Due in Two Years Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Operating Leases, Rent Expense, Net Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Accrued Liabilities, Current Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Accrued Liabilities, Noncurrent Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. View
us-gaap Other Assets Amount of assets classified as other. View
us-gaap Other Employee-related Liabilities, Current Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Other Receivables, Net, Current Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. View
us-gaap Payments of Debt Issuance Costs The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. View
us-gaap Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Collection of Advance to Affiliate The cash inflow from the collection of money previously advanced to an entity that is related to it but not strictly controlled. View
us-gaap Proceeds from Contributed Capital The cash inflow associated with the amount received by a corporation from a shareholder during the period. View
us-gaap Proceeds from Grantors Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from Other Equity Amount of cash inflow from the issuance of equity classified as other. View
us-gaap Proceeds from (Repayments of) Debt The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings. View
us-gaap Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. View
us-gaap Proceeds from (Repayments of) Related Party Debt Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. View
us-gaap Proceeds from Short-term Debt, Maturing in More than Three Months The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year). View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period. View
us-gaap Proceeds from Unsecured Notes Payable The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral). View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable. View
us-gaap Receivable from Officers and Directors for Issuance of Capital Stock Amounts receivable from officers and directors resulting from the sale of stock to officers or directors before the cash payment is received. View
us-gaap Receivables, Net, Current The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. View
us-gaap Related Party Transaction, Rate Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Repayments of Other Debt Amount of cash outflow for the payment of debt classified as other. View
us-gaap Repayments of Short-term Debt The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Number of equity instruments other than options outstanding, including both vested and non-vested instruments. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares authorized for issuance under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenue from Grants (Deprecated 2018-01-31) Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. View
us-gaap Revenue Other Manufactured Products (Deprecated 2018-01-31) Amount of revenue from the sale of manufactured products, classified as other. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Sale of Stock, Number of Shares Issued in Transaction The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Revenue, Net (Deprecated 2018-01-31) Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. View
us-gaap Secured Debt, Current Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Net number of non-option equity instruments granted to participants. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued The number of shares or units of entity securities issued in the transaction in which equity securities were issued to pay for goods or nonemployee services. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares Number of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted average grant-date fair value of non-vested options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value of options vested. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. View
us-gaap Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury. View
us-gaap Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date. View
us-gaap Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. View
us-gaap Stockholders' Equity, Other This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Value, Purchase of Assets Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) Value of stock issued as a result of the exercise of stock options, after deduction of related income tax (expense) benefit. View
us-gaap Stock Redeemed or Called During Period, Value Equity impact of the value of stock bought back by the entity at the exercise price or redemption price. View
us-gaap Unsecured Debt, Current Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer. View
us-gaap Warrants Not Settleable in Cash, Fair Value Disclosure Fair value portion of warrants not settleable in cash classified as equity. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
Chart of Accounts => Accounts
Name View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value View
Increase (Decrease) in Employee Related Liabilities View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Notes Payable, Current View
Notes Payable, Related Parties, Current View
Notes Payable, Related Parties, Current (Deprecated 2009-01-31) View
Notes Reduction View
Operating Expenses View
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit View
Stock Issued View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Shares, Other View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) View
Stock Issued During Period, Value, Issued for Services View
Accounts and Other Receivables, Net, Current View
Accounts Payable and Accrued Liabilities, Noncurrent View
Accounts Payable, Current View
Construction Contractor, Receivable, Excluding Contract Retainage View
Accretion Expense, Including Asset Retirement Obligations View
Accrued Bonuses, Current View
Accrued Liabilities, Current View
Accrued Liabilities View
Accrued Professional Fees, Current View
Accrued Salaries, Current View
Accrued Salaries View
Accrued Vacation, Current View
Accrued Vacation View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature View
Adjustments to Additional Paid in Capital, Other View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Warrant Issued View
Accounts Receivable, Allowance for Credit Loss, Current View
Allowance for Doubtful Other Receivables, Current View
Allowance for Loan and Lease Losses, Recoveries of Bad Debts (Deprecated 2013-01-31) View
Amortization of Debt Discount (Premium) View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Asset Impairment Charges View
Assets View
Assets, Current View
Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) View
Bridge Loan View
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash Equivalents, at Carrying Value View
Cash, Period Increase (Decrease) View
Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) View
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right View
Class of Warrant or Right, Outstanding View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Conversion of Stock, Amount Issued View
Conversion of Stock, Shares Converted View
Conversion of Stock, Shares Issued View
Cost of Revenue View
Debt Conversion, Converted Instrument, Amount View
Debt Conversion, Converted Instrument, Shares Issued View
Debt Conversion, Original Debt, Amount View
Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) View
Debt Instrument, Face Amount View
Debt Instrument, Interest Rate, Effective Percentage View
Debt Instrument, Interest Rate, Stated Percentage View
Debt Instrument, Redemption Price, Percentage View
Debt Instrument, Unamortized Discount View
Debt Issuance Cost (Deprecated 2016-01-31) View
Debt Issuance Costs, Current, Net View
Deferred Tax Assets, in Process Research and Development View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Property, Plant and Equipment View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals View
Deferred Tax Assets, Valuation Allowance, Current View
Deferred Tax Assets, Valuation Allowance, Noncurrent View
Defined Contribution Plan, Employer Discretionary Contribution Amount View
Deposits Assets, Noncurrent View
Depreciation, Depletion and Amortization, Nonproduction View
Depreciation, Depletion and Amortization View
Depreciation, Nonproduction View
Derivative, Gain (Loss) on Derivative, Net View
Derivative Liability, Current View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Due from Related Parties, Noncurrent View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Employee-related Liabilities, Current View
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
General and Administrative Expense View
Grants Receivable View
Grants Receivable, Current View
Gross Profit View
Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accounts Payable, Trade View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Derivative Liabilities View
Increase (Decrease) in Other Receivables View
Increase (Decrease) in Prepaid Expense and Other Assets View
Interest Expense View
Interest Expense, Debt View
Interest Income, Other View
Interest Payable View
Investment Income, Interest View
Issuance of Stock and Warrants for Services or Claims View
Operating Leases, Rent Expense View
Leveraged Buyout, Ownership Interest of New Investors (Deprecated 2013-01-31) View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) View
License and Services Revenue (Deprecated 2018-01-31) View
License Costs (Deprecated 2018-01-31) View
Notes Payable, Noncurrent View
Long-term Purchase Commitment, Amount View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Income (Loss) Attributable to Parent View
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued View
Nonoperating Income (Expense) View
Financing Receivable, after Allowance for Credit Loss, Current View
Notes Assumed View
Notes Issued View
Operating Income (Loss) View
Operating Leases, Future Minimum Payments Due, Next Twelve Months View
Operating Leases, Future Minimum Payments, Due in Two Years View
Operating Leases, Rent Expense, Net View
Operating Loss Carryforwards View
Other Accrued Liabilities, Current View
Other Accrued Liabilities, Noncurrent View
Other Assets View
Other Employee-related Liabilities, Current View
Other Nonoperating Income View
Other Nonoperating Income (Expense) View
Other Receivables, Net, Current View
Payments of Debt Issuance Costs View
Payments to Acquire Property, Plant, and Equipment View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Issued View
Prepaid Expense and Other Assets, Current View
Proceeds from Collection of Advance to Affiliate View
Proceeds from Contributed Capital View
Proceeds from Grantors View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Convertible Preferred Stock View
Proceeds from Issuance of Debt View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance of Warrants View
Proceeds from Issuance or Sale of Equity View
Proceeds from Notes Payable View
Proceeds from Other Equity View
Proceeds from (Repayments of) Debt View
Proceeds from (Repayments of) Notes Payable View
Proceeds from (Repayments of) Related Party Debt View
Proceeds from Short-term Debt, Maturing in More than Three Months View
Proceeds from Stock Options Exercised View
Proceeds from Stock Plans View
Proceeds from Unsecured Notes Payable View
Proceeds from Warrant Exercises View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Property, Plant and Equipment, Gross View
Property, Plant and Equipment, Net View
Accounts Receivable, Credit Loss Expense (Reversal) View
Receivable from Officers and Directors for Issuance of Capital Stock View
Receivables, Net, Current View
Related Party Transaction, Rate View
Repayments of Notes Payable View
Repayments of Other Debt View
Repayments of Short-term Debt View
Research and Development Expense View
Retained Earnings (Accumulated Deficit) View
Revenue from Grants (Deprecated 2018-01-31) View
Revenue Other Manufactured Products (Deprecated 2018-01-31) View
Revenues View
Sale of Stock, Number of Shares Issued in Transaction View
Sale of Stock, Price Per Share View
Revenue, Net (Deprecated 2018-01-31) View
Secured Debt, Current View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized View
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding View
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit View
Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value View
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price View
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price View
Shares, Outstanding View
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest View
Stockholders' Equity, Other View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Stock Issued During Period, Value, Purchase of Assets View
Stock Issued During Period, Value, Stock Options Exercised View
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) View
Stock Redeemed or Called During Period, Value View
Unsecured Debt, Current View
Warrants Not Settleable in Cash, Fair Value Disclosure View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View